Monthly E-News Update
Having trouble reading this email?
View it on your browser
Forward this message to a Friend
The Alzheimer's Association International Conference® 2016 (AAIC®) is underway. Thousands of international investigators, clinicians and care providers are coming together to share their results, theories and discoveries about Alzheimer's disease and other dementias. During the first three days of AAIC 2016, world-renowned experts introduced cutting-edge breakthroughs in Alzheimer's science that have the potential to change the field. Some of the most promising news includes:
  • Novel research from Canadian scientists on Parkinson's and Alzheimer's pathology could help identify new ways to treat the diseases.
  • An innovative program in Australia has reduced the use of antipsychotic drugs in dementia treatment in long-term care settings; in the United States, one-quarter of dementia patients are inappropriately treated with drugs that cause sedation.
  • A new American study suggests that treating people with Alzheimer's disease may increase survival and incur less overall cost of care than non-treatment.
As we work together to fight this devastating disease, we are happy to share progress and resources made possible by the support provided from generosity like yours.
Care and support service announced by Centers for Medicare & Medicaid Services
A new Medicare service — which would allow those diagnosed with Alzheimer's disease to receive comprehensive care planning services through a medical visit — has been announced by the Centers for Medicare & Medicaid Services (CMS). This decision comes after increasing bipartisan congressional support for the HOPE for Alzheimer's Act. The Alzheimer's Association has been leading this effort on multiple fronts with Congress and the administration. CMS will accept public comment, and the Alzheimer's Association wants your input if you have dementia or are a caregiver or a health care provider. When implemented, the Medicare benefit will go into effect Jan. 1, 2017. Learn more.
Alzheimer's Research Funding Receives Bipartisan Support in House
Today, the House Appropriations Committee approved an additional $350 million for Alzheimer's disease research. The Alzheimer's Association and its advocates applaud the bipartisan action of the House Appropriations Committee to approve a significant increase for Alzheimer's research funding at the NIH. Learn more.
Walk with us in the fight against Alzheimer's
In case you missed the announcement in our last newsletter, NARFE is now a proud National Team for the Alzheimer's Association Walk to End Alzheimer's®! Learn more about how to register and get involved in your local Walk (there are over 600 events) across the country — please visit
Online Tools
Alzheimer's Association International Conference
Alzheimer's Disease Facts and Figures
Join Our Mailing List

NARFE Contributions to Advance Alzheimer's Research

Your donation goes directly to support research through the NARFE Alzheimer's Fund.
Help us reach our NEW goal of $12 million!

24/7 Helpline: 1-800-272-3900
The Alzheimer's Association is the leading voluntary health organization in Alzheimer's care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's disease®.

Alzheimer's Association National Office, 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601
© 2016 Alzheimer's Association. All rights reserved.
800.272.3900 |® | Donate

View your email preferences or unsubscribe.